MF
TLSI icon

Magnetar Financial’s TriSalus Life Sciences TLSI Stock Holding History

Magnetar Financial’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,232
Closed -$65.6K – 788
2024
Q3 		$65.6K Buy
+14,232
New +$75.4K ﹤0.01% 499
2023
Q3 		– Sell
-700,000
Closed -$7.34M – 581
2023
Q2 		$7.34M Sell
700,000
-445,828
-39% -$4.64M 0.16% 106
2023
Q1 		$11.8M Hold
1,145,828
– – 0.23% 98
2022
Q4 		$11.5M Sell
1,145,828
-135,119
-11% -$1.35M 0.19% 133
2022
Q3 		$12.7M Sell
1,280,947
-410,573
-24% -$4.06M 0.18% 152
2022
Q2 		$16.6M Hold
1,691,520
– – 0.17% 110
2022
Q1 		$16.6M Buy
1,691,520
+62,107
+4% +$613K 0.18% 118
2021
Q4 		$16.1M Sell
1,629,413
-114,004
-7% -$1.13M 0.16% 140
2021
Q3 		$17.3M Buy
+1,743,417
New +$17.1M 0.18% 124

Other funds holding TLSI

WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Magnetar Financial's TLSI Position: Q4 2024 in Review

Magnetar Financial sold out of TriSalus Life Sciences (TLSI) in Q4 2024, closing a stake of 14,232 shares — an estimated $65.6K sold.

Magnetar Financial first reported a position in TLSI in Q3 2021 and held it in 9 quarters. The position peaked at $17.3M in Q3 2021. 30 funds tracked by Wall St. Rank hold TLSI as of Q4 2024.

  • Magnetar Financial reported no remaining TriSalus Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Magnetar Financial sold 14,232 TriSalus Life Sciences shares in Q4 2024, an estimated $65.6K.
  • Magnetar Financial first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 9 quarters.
  • Magnetar Financial's TriSalus Life Sciences position peaked at $17.3M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2024.

Based on Magnetar Financial's 13F filing for Q4 2024, filed 11 Feb 2025.